{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 253,
  "pageCount": 415,
  "prevPage": 252,
  "nextPage": 254,
  "slideType": "quote_slide",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a quote to undermine the credibility of the company's clinical trial data by highlighting the difference between controlled trial environments and real-world application.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/253",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-253",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Soleno has done a pretty good job of drumming that up with their informercials or whatever you want to call them...once it gets out there for a little bit and we get some more real-world data...who aren't screened and vetted...like a perfect fit for a clinical trial...I don't know what we're going to see.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ab-ee85f319925c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.31
      },
      "kind": "quote",
      "text": "Hype created by Soleno in PWS community at risk “once it gets out there for a little bit” with real-world realities\n“I keep telling people, I think that there's obviously a lot of hype in the community, but Soleno has done a pretty good job of drumming that with their informercials or whatever you want to call them. People are excited, but people are also now starting — I just think that once it gets out there for a little bit and we get some more real-world data, once we get more people on it who aren't screened and vetted, and just like a perfect fit for a clinical trial, I don't know what we're going to see.” – KOL in the PWS field; involved with Soleno's clinical program",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f292996-2efb-4ba9-8fb3-258372471326",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "I keep telling people, I think that there's obviously a lot of hype in the community, but Soleno has done a pretty good job of drumming that with their informercials or whatever you want to call them. People are excited, but people are also now starting — I just think that once it gets out there for a little bit and we get some more real-world data, once we get more people on it who aren't screened and vetted, and just like a perfect fit for a clinical trial, I don't know what we're going to see. — KOL in the PWS field; involved with Soleno's clinical program",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ab-f08897fc9c3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77dae7a7-08f6-44d1-84d1-aa37abd13cc1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The KOL stated that Soleno’s hype faces an imminent reckoning as real-world patients trial it vs. the ultra-small, cherry-picked sample in the trials – “Soleno has done a pretty good job of drumming that up with their informercials or whatever you want to call them…once it gets out there for a little bit and we get some more real-world data…who aren’t screened and vetted…like a perfect fit for a clinical trial…I don’t know what we’re going to see.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98f9392b-9f46-4adb-bb90-2a31c6438429",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "4f2e9791-6768-4866-b0c2-def5569345fd",
      "evidence": "Uses a KOL quote to validate the argument against the company's trial methodology.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}